Strengthening your trial strategy with HTA-aligned evidence

About this session

- Design trials that support both CE marking and joint clinical assessment
- Anticipate decision makers’ expectations when choosing clinical endpoints
- Avoid duplication of evidence generation by aligning early

Speakers

• 

  Leslie Pibouleau

  Policy Officer · European Commission Directorate-General for Health and Food Safety - SANTE

  Speaker

• 

  Alexandra Poulsson

  Co-Chair of the JSC Subgroup and Senior Advisor for HTA · Norwegian Medical Products Agency

  Speaker